Clinical Trials Logo
  1. Home
  2. Ovarian Cysts
  3. NCT02129036
  4. Details
NCT02129036 Clinical Trial

Ovarian Clear Cell Adenocarcinoma Review

Ovarian Cysts Clinical Trial

— OCCA  

Official title:
Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02129036
Other study ID # TGOG-127
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2008
Est. completion date December 2013

Study information
Verified date April 2014
Source Cathay General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Clear cell carcinoma comprises 5-10% of surface epithelial ovarian cancers, and about 30-40% of the patients with clear cell carcinoma are diagnosed in the advanced stage. The investigators studied the response to chemotherapy and survival for either paclitaxel-platinum based chemotherapy or conventional platinum-based chemotherapy among all stages clear cell ovarian carcinoma. Prognostic factors for survival among the patients with pure, advanced, clear cell ovarian carcinoma were also evaluated.

Description:

1. Several authors have reported frequent admixtures of clear cell ovarian carcinoma with serous, mucinous, and endometrioid tumors. However, few papers addressed the difference in response to chemotherapy and survival between patients with pure and mixed-type advanced clear cell carcinoma.

2. Recent trends in the clinical management of advanced ovarian cancer include increased attention to maximal cytoreduction and general acceptance of paclitaxel-platinum-based adjuvant chemotherapy.

3. The introduction of paclitaxel markedly changed the postoperative management of ovarian cancer patients, but the results and value of these newer efforts and therapies applied to clear cell carcinoma are as yet undetermined.

4. Today, paclitaxel-platinum-based chemotherapy is becoming the standard regimen for ovarian cancer worldwide. Previous research suggests a potential benefit of paclitaxel plus carboplatin regimens for stage I clear cell carcinoma. However, few papers specifically addressed the efficacy of paclitaxel-platinum-based chemotherapy for advanced clear cell carcinoma because clear cell carcinoma occurs only rarely in Western countries.

Recruitment information / eligibility
Status Completed
Enrollment 5
Est. completion date December 2013
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Female
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of Ovarian clear cell carcinoma

Exclusion Criteria:

- not undergo operation

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Cathay General Hospital National Taiwan University Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary Overall survival (OS) Overall survival (up to 6 years)
See also
  Status Clinical Trial Phase
Completed NCT02890914 - Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents N/A
Completed NCT01779232 - Danazol Treatment in Endometriosis Women Before IVF Phase 4
Completed NCT05054946 - The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types N/A
Completed NCT02852447 - The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve N/A
Completed NCT00713778 - The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Phase 4
Suspended NCT00865488 - Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery Phase 3
Completed NCT04142203 - Implementation of 23 Hour Surgery Model in a Tertiary Hospital
Recruiting NCT05842629 - Improved Diagnosis of Ovarian Cancer
Completed NCT05376384 - Ovarian Cyst's Enucleation Spillage Score
Recruiting NCT04993924 - GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst Phase 4
Terminated NCT03189316 - Anti-inflammatory Cells in Peritoneal Cavity N/A
Completed NCT05800613 - Management of Ovarian Masses in Pediatric Patients: an Italian Survey
Completed NCT04355312 - Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy N/A
Completed NCT05418595 - Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT06342934 - Radiomics and Machine Learning in the Diagnosis of Ovarian Masses
Completed NCT06227676 - Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 Phase 2/Phase 3
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Recruiting NCT05763511 - Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Completed NCT06064331 - Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements N/A
Recruiting NCT02086318 - A New Algorithm to Predict Ovarian Age N/A